Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the PPARy Agonist Rosiglitazone on Airway Hyperreactivity

NCT00614874 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.

NCT NCT00614874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00614874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the PPARy Agonist Rosiglitazone on Airway Hyperreactivity
Lead sponsor
Creighton University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
March 31, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma